SILVERLOCK MEDICAL CENTRE
2 VERNEY WAY, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 29 | 45 | 64.4% | |
| CKD 4 | 2008 | 35 | 46 | 76.1% | |
| CKD 5 | 2009 | 15 | 18 | 83.3% | |
| CKD 5 | 2010 | 1 | 1 | 100.0% | |
| CKD 5 | 2011 | 3 | 3 | 100.0% | |
| CKD 5 | 2012 | 2 | 2 | 100.0% | |
| CKD 5 | 2013 | 1 | 1 | 100.0% | |
| CKD003 | 2014 | 1 | 1 | 100.0% | |
| CKD003 | 2015 | 1 | 1 | 100.0% | |
| NM84 | 2016 | 1 | 1 | 100.0% | |
| NM84 | 2017 | 1 | 2 | 50.0% | |
| NM84 | 2018 | 3 | 5 | 60.0% | |
| NM84 | 2019 | 12 | 17 | 70.6% | |
| NM84 | 2020 | 12 | 20 | 60.0% | |
| NM84 | 2022 | 13 | 20 | 65.0% | |
| NM84 | 2023 | 9 | 18 | 50.0% |
